On average it takes 10 years and 800 million to bring a new drug to market. Biotech is a complex and unpredictable business. Both products have made fatastic progress over the past 10 years - so to write them off as do nothing products is naive and smacks more of a common line used by predatory hedge funds.
Speaking of hedge funds, Adam's little hit piece oozes desperation. The predatory hedge fund needs selling volume and they are not getting it. They have been betting against the company all along and now know they made the wrong bet, all the while holding a large short position.
From 2 different PRs
"Hemispherx is working with regulatory authorities to potentially inhibit further escalation of this global crisis."
Surgeon General, Major General Andreas Stettbacher, said “We need an effective, convenient-to-use, and widely administrable preventative and therapeutic for pandemic influenza outbreak to accompany the commitment the Swiss Military has made to a rapid, point-of-care diagnostic test for H7N9 to provide a “1:2 punch” to a pandemic threat or outbreak and under our Agreement with the US Department of Defense. Based on research to date, Alferon® is a promising drug candidate.”
Stettbacher was taking about H7N9 , but the same could be applied to Ebola. Both the oral form of alferon and the nasal form of ampligen can be "widely administrable". I don't think there are any other drugs, that can be ready to go, widely, for the current ebola crisis.
